DuoGenic StemCells corporation
7607
Rank in Stocks
#27719
Duogenic Stemcells Corporation is primarily engaged in the biotechnology and... Duogenic Stemcells Corporation is primarily engaged in the biotechnology and healthcare industries, offering a variety of services. Their core offerings include cell therapy and the development of closed-culture cell systems. The company was established on March 22, 2018, and its main corporate office is situated in Taichung, Taiwan.
Share Price
$0.37800729
Last synced: 2026-11-10
Market Cap
$13.86M
Change (1 day)
5.08%
Change (1 year)
-35.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade DuoGenic StemCells corporation (7607)
Category
Healthcare
Operating Margin for DuoGenic StemCells corporation (7607)
Operating Margin as of November 2026 TTM: -166.97%
According to DuoGenic StemCells corporation's latest financial reports, its current operating margin (TTM) is -166.97%. At the end of 2025 the company had an operating margin of -124.65%.
Operating Margin history for DuoGenic StemCells corporation from 2021 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -166.97% | 33.95% |
| 2025 | -124.65% | -75.38% |
| 2024 | -506.23% | 54.14% |
| 2023 | -328.42% | -32.57% |
| 2022 | -487.03% | -51.66% |
| 2021 | -1,007.49% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 18.91% | -100.11% |
IE
|
|
| 10.95% | -100.07% |
CN
|
|
| 25.26% | -100.15% |
CH
|
|
| 13.54% | -100.08% |
CH
|
|
| 38.62% | -100.23% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about DuoGenic StemCells corporation's operating margin
What is DuoGenic StemCells corporation's operating margin?
DuoGenic StemCells corporation's operating margin is -166.97%, as of Nov 2026.
What was DuoGenic StemCells corporation's operating margin in 2025?
In 2025, DuoGenic StemCells corporation's operating margin was -124.65%, compared with -506.23% in 2024.
How has DuoGenic StemCells corporation's operating margin changed since 2021?
From 2021 to 2025, DuoGenic StemCells corporation's operating margin was highest in 2025 (-124.65%) and lowest in 2021 (-1,007.49%).
How does DuoGenic StemCells corporation's operating margin compare with similar companies?
DuoGenic StemCells corporation's operating margin (-166.97%) is lower than that of all 5 similar companies listed above. The highest among them is Jafron Biomedical Co.,Ltd., with 38.62%.